Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201208130 Principal Investigator: Picus, Joel
Title: A Randomized Phase 3 Study Comparing Cabazitaxel/Prednisone in Combination with Custirsen (OGX-011) to Cabazitaxel/Prednisone for Second-Line Chemotherapy in Men with Metastatic Castrate Resistant Prostate Cancer
Phase: III Disease Site: Prostate
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if being treated with cabazitaxel, prednisone and the experimental drug custirsen is better than cabazitaxel and prednisone alone at increasing survival in subjects with metastatic, castrate resistant prostate cancer. The study will also see if custirsen is safe when given with cabazitaxel and prednisone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)